Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Free Cash Flow (2016 - 2026)

Dexcom has reported Free Cash Flow over the past 17 years, most recently at $449.0 million for Q1 2026.

  • Quarterly Free Cash Flow rose 363.84% to $449.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Mar 2026, up 148.5% year-over-year, with the annual reading at $1.1 billion for FY2025, 70.79% up from the prior year.
  • Free Cash Flow was $449.0 million for Q1 2026 at Dexcom, up from $192.1 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $579.4 million in Q3 2025 and troughed at -$30.6 million in Q1 2022.
  • The 5-year median for Free Cash Flow is $152.3 million (2024), against an average of $174.9 million.
  • Year-over-year, Free Cash Flow tumbled 59.64% in 2024 and then skyrocketed 556.17% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $69.0 million in 2022, then increased by 17.54% to $81.1 million in 2023, then soared by 118.0% to $176.8 million in 2024, then increased by 8.65% to $192.1 million in 2025, then skyrocketed by 133.73% to $449.0 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Free Cash Flow are $449.0 million (Q1 2026), $192.1 million (Q4 2025), and $579.4 million (Q3 2025).